- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Gufic Biosciences Limited — Updates, 14-08-2026: General Updates
14-08-2026 | 08:18 pm
14-08-2026 | 08:18 pm
Gufic Biosciences reported Q1 FY27 revenue of 260.8 Cr and PAT of 22.0 Cr. The Indore facility's depot and microsphere suite nears completion. The company launched AWABAC for critical infections, secured international approvals across eight countries, and partnered with a global health organization for complex injectables.
No comments yet. Be the first to comment!